These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 32744944

  • 1. Medicare Part D Plans Rarely Cover Brand-Name Drugs When Generics Are Available.
    Dusetzina SB, Cubanski J, Nshuti L, True S, Hoadley J, Roberts D, Neuman T.
    Health Aff (Millwood); 2020 Aug; 39(8):1326-1333. PubMed ID: 32744944
    [Abstract] [Full Text] [Related]

  • 2. Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part D.
    Dusetzina SB, Sarpatwari A, Carrier MA, Hansen RA, Keating NL, Huskamp HA.
    JAMA Intern Med; 2021 Dec 01; 181(12):1605-1611. PubMed ID: 34661600
    [Abstract] [Full Text] [Related]

  • 3. Trends in Medicare Part D coverage of generics with equivalent brand-name drugs.
    Dusetzina SB, Cubanski J, Roberts AW, Hoadley J, True S, Nshuti L, Neuman T.
    Am J Manag Care; 2021 Jul 01; 27(7):283-288. PubMed ID: 34314117
    [Abstract] [Full Text] [Related]

  • 4. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM, Urmie JM, Farris KB, Doucette WR.
    Res Social Adm Pharm; 2010 Jun 01; 6(2):100-9. PubMed ID: 20511109
    [Abstract] [Full Text] [Related]

  • 5. In Medicare Part D plans, low or zero copays and other features to encourage the use of generic statins work, could save billions.
    Hoadley JF, Merrell K, Hargrave E, Summer L.
    Health Aff (Millwood); 2012 Oct 01; 31(10):2266-75. PubMed ID: 23048108
    [Abstract] [Full Text] [Related]

  • 6. Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents.
    Sacks CA, Lee CC, Kesselheim AS, Avorn J.
    JAMA; 2018 Aug 21; 320(7):650-656. PubMed ID: 30140875
    [Abstract] [Full Text] [Related]

  • 7. Sending The Wrong Price Signal: Why Do Some Brand-Name Drugs Cost Medicare Beneficiaries Less Than Generics?
    Dusetzina SB, Jazowski S, Cole A, Nguyen J.
    Health Aff (Millwood); 2019 Jul 21; 38(7):1188-1194. PubMed ID: 31260351
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.
    Patel RA, Walberg MP, Tong E, Tan F, Rummel AE, Woelfel JA, Carr-Lopez SM, Galal SM.
    J Manag Care Spec Pharm; 2014 Mar 21; 20(3):283-90. PubMed ID: 24564812
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
    Hwang TJ, Jain N, Lauffenburger JC, Vokinger KN, Kesselheim AS.
    JAMA Intern Med; 2019 Mar 01; 179(3):374-380. PubMed ID: 30640379
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Trends in Utilization and Cost of Low-Density Lipoprotein Cholesterol-Lowering Therapies Among Medicare Beneficiaries: An Analysis From the Medicare Part D Database.
    Sumarsono A, Lalani HS, Vaduganathan M, Navar AM, Fonarow GC, Das SR, Pandey A.
    JAMA Cardiol; 2021 Jan 01; 6(1):92-96. PubMed ID: 32902560
    [Abstract] [Full Text] [Related]

  • 15. Variation in generic dispensing rates in Medicare Part D.
    Buttorff C, Xu Y, Joyce G.
    Am J Manag Care; 2020 Nov 01; 26(11):e355-e361. PubMed ID: 33196286
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF, Escarce JJ, Solomon MD, Goldman DP.
    JAMA; 2002 Oct 09; 288(14):1733-9. PubMed ID: 12365957
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.